Sort
64,565 grants matching “drug discovery”
Plasma-Generated Hydroxyl Radicals for Analysis of Three-Dimensional Structures in Protein Therapeutics
$1,037,792Faraz Choudhury · Immuto Scientific, Inc. · R44 · FY2022 · GM
Reading mitochondrial apoptotic signaling to identify active cancer therapeutics
$1,037,388Anthony G Letai · Dana-Farber Cancer Inst · R35 · FY2021 · CA
Functional Genomics Laboratory (FGL)
$1,037,104Ken Cheng · National Center For Advancing Translational Sciences · ZIC · FY2025 · TR
Metabolic Discrimination of Unknown Bacterial Pathogens
$1,036,884John Peter Wikswo · Vanderbilt University · U01 · FY2007 · AI
Molecular Targets Phase III CoBRE
$1,036,424Donald M Miller · University Of Louisville · P30 · FY2017 · GM
Structure and Function of Neurotransmitter Transporters
$1,036,387Harel Weinstein · Weill Medical Coll Of Cornell Univ · P01 · FY2008 · DA
Novel small-molecule therapies for CF
$1,036,332Alan S Verkman · University Of California, San Francisco · P30 · FY2009 · DK
Next-generation 5-nitroimidazoles against giardiasis
$1,036,268Lars Eckmann · University Of California, San Diego · U01 · FY2011 · AI
Selection of a lead LPAR1 antagonist for treatment of diabetic neuropathy
$1,035,811Graham Beaton · Epigen Biosciences, Inc. · R44 · FY2021 · DK
Chemistry Core
$1,035,799Timothy S Bugni · University Of Wisconsin-Madison · U19 · FY2023 · AI
Novel small-molecule therapies for CF
$1,035,766Alan S Verkman · University Of California, San Francisco · P30 · FY2008 · DK
Identifying novel anti-infectives by high through-put screening in whole animals
$1,035,268Frederick M Ausubel · Massachusetts General Hospital · R01 · FY2012 · AI
Comprehensive Cancer Center Program at Fox Chase
$1,035,145Jonathan D. Chernoff · Research Inst Of Fox Chase Can Ctr · P30 · FY2021 · CA
A 3D vascularized islet biomimetic to model type 1 diabetes
$1,035,118Maike Sander · University Of California, San Diego · UG3 · FY2020 · DK
Nanodiamond Quantum Sensors for Free Radical Detection
$1,034,967Marco Torelli · Adamas Nanotechnologies, Inc. · R44 · FY2024 · TR
A multidisciplinary approach to elucidating gene function in a model Gram-positiv
$1,034,875David Z Rudner · Harvard Medical School · RC2 · FY2010 · GM
Discovery of PSD95 protein-protein interaction inhibitors as novel non-opioid analgesics
$1,034,659Stephanie K Florio · Anagin · U44 · FY2023 · NS
Molecular Studies of Malformations
$1,034,538Leslie Biesecker · National Human Genome Research Institute · ZIA · FY2015 · HG
Tri-Institutional Tuberculosis Research Advancement Center (TRAC)
$1,034,397Daniel W Fitzgerald · Weill Medical Coll Of Cornell Univ · P30 · FY2022 · AI
Development and Testing of New Computational Methods for Ligand Discovery and Mechanism
$1,034,213Brian K. Shoichet · University Of California, San Francisco · R35 · FY2021 · GM
Development and Testing of New Computational Methods for Ligand Discovery and Mechanism
$1,034,213Brian K. Shoichet · University Of California, San Francisco · R35 · FY2020 · GM
The Cancer Target Discovery and Development Network at UCSF
$1,034,211Michael T McManus · University Of California, San Francisco · U01 · FY2017 · CA
CONUS PEPTIDES AND THEIR RECEPTOR TARGETS
$1,034,205University Of Utah · P01 · FY2002 · GM
Genomic Medicine Implementation: The Personalized Medicine Program
$1,034,134Julie A. Johnson · University Of Florida · U01 · FY2016 · HG
Development of novel proteins synthesis inhibitors for MDR tuberculosis
$1,034,057Richard Edward Lee · St. Jude Children'S Research Hospital · R01 · FY2010 · AI